Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Mickey2on Jan 29, 2021 11:47am
125 Views
Post# 32420465

RE:RE:RE:1800 shares traded???????

RE:RE:RE:1800 shares traded???????the .2 dose results were really good.  I expect similar or better result with double dosage.
lets get some news soon

a mushroom in the dark.... lol i laughed at that one.
take care


pointer wrote:
Mickey2 wrote: John F. is that you? what are your thoughts on all those tweets all of a sudden?
how long does it take to analyze .4 dose data from the trial? Will we get to see it or will it remain confidential?

 


Yeah, Stockhouse fugging me around, again.
As for the tweet storm, it is either another pump-and-dump run or they are actually telegraphing something material coming. I am hoping for the latter.

SBM did tweet that we should be patient (what else have we been?) and that news was coming. Now, did they just mean news about the higher dose 1067 trial, which we now have, and some SGLT2 hints at greatness, which they keep harping on, or are they going to actually going to release news that has an effect on the share price? Again, I am hoping for the latter.

And they dam well better release the 1067 results.

But what do I know, I am just a mushroom like everyone else. (kept in the dark)


<< Previous
Bullboard Posts
Next >>